3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
102
Lung Neoplasms
39
Neoplasms
11
Neoplasm Metastasis
11
Colorectal Neoplasms
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Pancreatic Neoplasms
6
Mesothelioma, Malignant
5
Mesothelioma
5
Carcinoma
5
Ovarian Neoplasms
4
Meningeal Carcinomatosis
4
Melanoma
4
Colonic Neoplasms
4
Advanced Solid Tumors
4
Rectal Neoplasms
3
Adenocarcinoma of Lung
3
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Non-squamous Non-small Cell Lung Cancer
2
Neoplasms by Site
2
Lung Diseases
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Pancreatic Ductal
2
Carcinoma, Bronchogenic
2
Bronchial Neoplasms
2
Brain Neoplasms
2
Interventions
Rituximab
27
acalabrutinib
15
ibrutinib
13
Cyclophosphamide
12
Lenalidomide
10
CT-P10
10
zanubrutinib
9
venetoclax
9
Magnetic Resonance Spectroscopy
8
obinutuzumab
7
Specimen Handling
7
Cytarabine
7
Bendamustine Hydrochloride
7
pirtobrutinib
6
fludarabine
6
Biopsy
6
glofitamab
5
fludarabine phosphate
5
Peripheral Blood Stem Cell Transplantation
5
Cyclosporine
5
brexucabtagene autoleucel
4
Whole-Body Irradiation
4
Mycophenolic Acid
4
Vincristine
3
Stem Cell Transplantation
3
Sirolimus
3
Methotrexate
3
Etoposide
3
Doxorubicin
3
Cyclosporins
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
Pemetrexed
×
90 days
×
Clear all
No trials found.